Skip to main content
Chabiotech Co.,Ltd. logo

Chabiotech Co.,Ltd. — Investor Relations & Filings

Ticker · 085660 ISIN · KR7085660009 KO Professional, scientific and technical activities
Open in API
Filings indexed 460 across all filing types
Latest filing 2025-02-07 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 085660

About Chabiotech Co.,Ltd.

http://en.chabio.com/

Chabiotech Co., Ltd. is a biotechnology company specializing in the research and development of cell and gene therapies for rare cancers and incurable diseases. The company's core activities include advancing its therapeutic pipelines and providing global Contract Development and Manufacturing Organization (CDMO) services for advanced biopharmaceuticals, including full-scale GMP production and testing. Chabiotech also operates bio-banking services, such as cord blood and immune/stem cell storage, utilizing advanced cryopreservation technology. Its diversified business segments extend to genomics for precision medicine, healthcare IT solutions that integrate AI and Big Data, comprehensive wellness programs, and specialized healthcare consulting.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding a 'Decision on Paid-in Capital Increase' (유상증자결정). It details specific changes to the capital structure, including subscription dates, payment dates, and share allocation ratios. This is a formal regulatory filing concerning capital changes and share issuance, which falls under the 'Share Issue/Capital Change' category.
2025-02-07 Korean
[기재정정]증권신고서(지분증권) (2025.04)
Regulatory Filings Classification · 100% confidence The document is a '증권신고서(지분증권) 정정신고' (Securities Registration Statement Amendment) filed by Cha Biotech. It details amendments to a previously filed securities registration statement, including updates to the offering schedule, risk factors, and business descriptions. This is a formal regulatory filing required for public offerings of equity securities, which falls under the category of Regulatory Filings (RNS) as it is a specific legal document submitted to the financial regulator (DART/FSS).
2025-02-07 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document details the shareholding status of major shareholders and their special related parties, including changes in collateralized share agreements. It is a formal disclosure of significant share ownership and related changes, which falls under the 'Major Shareholding Notification' category.
2025-01-22 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding a 'Decision on Paid-in Capital Increase' (유상증자결정). It details the amendment of the capital increase schedule, including changes to the subscription dates, payment dates, and listing dates for new shares. This document is a formal regulatory filing in Korea (DART system) concerning capital structure changes and share issuance. It falls under the 'Share Issue/Capital Change' category as it specifically outlines the terms and adjustments of a capital increase.
2025-01-20 Korean
[기재정정]증권신고서(지분증권) (2025.03)
Capital/Financing Update Classification · 98% confidence The document is a '증권신고서(지분증권) 정정신고' (Amendment to Securities Registration Statement) filed by Cha Biotech. It details specific amendments to a previously filed securities registration statement, including updates to investment risk factors, business descriptions, and the offering schedule. This is a formal regulatory filing required by the Financial Supervisory Service (FSS) in South Korea for companies undergoing public offerings or capital changes. Since it is a formal regulatory amendment document rather than a simple announcement of a report, it falls under the category of Regulatory Filings.
2025-01-20 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding an upcoming 'Corporate Presentation' (IR) event scheduled for January 2025. It details the date, location, purpose, and participants of the roadshow. Since it is an announcement of an event rather than the presentation slides themselves, and it serves as a regulatory notification of corporate activity, it fits the 'Regulatory Filings' (RNS) category as a general announcement of company events.
2025-01-20 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.